Get the Stockscreener App
2.81
1.40%
-0.04
Pre-market:
2.81
Qualigen Therapeutics Inc stock is traded at $2.81, with a volume of 194.20K.
It is down -1.40% in the last 24 hours and down -46.27% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$2.85
Open:
$2.79
24h Volume:
194.20K
Relative Volume:
0.08
Market Cap:
$4.76M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-1.0564
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-5.39%
1M Performance:
-46.27%
6M Performance:
-19.71%
1Y Performance:
-42.89%
1-Day Range:
$2.79
$2.92
1-Week Range:
$2.6601
$3.36
52-Week Range:
$1.61
$8.81
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
2.81 | 5.79M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
Is Qualigen Therapeutics Inc. stock a safe investment in uncertain markets2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Can Qualigen Therapeutics Inc. (7R90) stock retain market dominance2025 AllTime Highs & Weekly High Return Opportunities - newser.com
Published on: 2025-11-03 08:42:41 - newser.com
How Qualigen Therapeutics Inc. stock compares to industry benchmarksWatch List & Entry Point Confirmation Signals - newser.com
Will Qualigen Therapeutics Inc. rebound enough to break evenQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock could be next leader2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Using fundamentals and technicals on Qualigen Therapeutics Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Using flow based indicators on Qualigen Therapeutics Inc.Bull Run & Stock Timing and Entry Methods - newser.com
Why Qualigen Therapeutics Inc. stock is trending among retail tradersJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Is Qualigen Therapeutics Inc. (7R90) stock a top pick for value investorsExit Point & Pattern Based Trade Signal System - newser.com
How Qualigen Therapeutics Inc. (7R90) stock trades in high volatilityWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - newser.com
Can swing trading help recover from Qualigen Therapeutics Inc. lossesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock attracts HNW investors2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock is a strong buy callEntry Point & AI Powered Buy/Sell Recommendations - newser.com
What insider purchases suggest about Qualigen Therapeutics Inc. (7R90) stockWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Can Qualigen Therapeutics Inc. stock weather global recessionCEO Change & Fast Momentum Stock Entry Tips - newser.com
What institutional flow reveals about Qualigen Therapeutics Inc.Trade Volume Report & Technical Entry and Exit Tips - newser.com
Automated trading signals detected on Qualigen Therapeutics Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - newser.com
Is Qualigen Therapeutics Inc. stock a safe buy before earnings2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Exit strategy if you’re trapped in Qualigen Therapeutics Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-02 21:07:13 - newser.com
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy - GlobeNewswire Inc.
Can Qualigen Therapeutics Inc. (7R90) stock sustain revenue momentum2025 Sector Review & Safe Entry Zone Tips - newser.com
Is Qualigen Therapeutics Inc. a candidate for recovery playStop Loss & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-02 07:20:20 - newser.com
Will a bounce in Qualigen Therapeutics Inc. offer an exitQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
Published on: 2025-11-02 01:49:21 - newser.com
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):